Fabrication and in vitro release behavior of a novel antibacterial coating containing halogenated furanone-loaded poly(L-lactic acid) nanoparticles on microarc-oxidized titanium

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5641-5652

  Cheng, Yicheng ^a   Wu, Jiang ^a   Gao, Bo ^a   Zhao, Xianghui ^a   Yao, Junyan ^b   Mei, Shenglin ^a   Zhang, Liang ^a   Ren, Huifang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

Author keywords

Antibacterial; Coating; Halogenated furanone; Microarc oxidation; Nanoparticles; Sustained release

Indexed keywords

4 BROMO 5 (BROMOMETHYLENE) 2 (5H) FURANONE POLY(LEVO LACTIC ACID) NANOPARTICLE; NANOCOATING; TITANIUM; UNCLASSIFIED DRUG;

ARTICLE; CROSS LINKING; DRUG COATING; DRUG RELEASE; IN VITRO STUDY; NANOANALYSIS; NANOENCAPSULATION; NANOFABRICATION; PARTICLE SIZE; STRUCTURE ANALYSIS;

ANTI-BACTERIAL AGENTS; BACTERIAL PHYSIOLOGICAL PHENOMENA; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; DELAYED-ACTION PREPARATIONS; DIFFUSION; ELECTROPLATING; FURANS; LACTIC ACID; NANOCAPSULES; OXIDATION-REDUCTION; POLYMERS; TITANIUM;

EID: 84870374505     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S37022     Document Type: Article

References (49)

1. Buser D, Mericske-Stern R, Bernard JP, etal. Long-term evaluation of non-submerged ITI implants. Part 1: 8-year life table analysis of a prospective multi-center study with 2359 implants. Clin Oral Implants Res. 1997;8:161-172.
2. Ekelund JA, Lindquist LW, Carlsson GE, Jemt T. Implant treatment in the edentulous mandible: a prospective study on Branemark system implants over more than 20 years. Int J Prosthodont. 2003;16:602-608.
3. Ferrigno N, Laureti M, Fanali S, Grippaudo G. A long-term follow-up study of non-submerged ITI implants in the treatment of totally edentulous jaws. Part I: Ten-year life table analysis of a prospective multicenter study with 1286 implants. Clin Oral Implants Res. 2002;13: 260-273.
4. Simonis P, Dufour T, Tenenbaum H. Long-term implant survival and success: a 10-16-year follow-up of non-submerged dental implants. Clin Oral Implants Res. 2010;21:772-777.
5. Palma-Carrio C, Maestre-Ferrin L, Penarrocha-Oltra D, Penarrocha-Diago MA, Penarrocha-Diago M. Risk factors associated with early failure of dental implants. A literature review. Med Oral Patol Oral Cir Bucal. 2011;16:e514-e517.
6. Schwartz-Arad D, Laviv A, Levin L. Failure causes, timing, and cluster behavior: an 8-year study of dental implants. Implant Dent. 2008;17: 200-207.
7. Lindhe J, Meyle J. Peri-implant diseases: consensus report of the sixth european workshop on periodontology. J Clin Periodontol. 2008;35: 282-285.
8. Heitz-Mayfield LJ. Peri-implant diseases: diagnosis and risk indicators. J Clin Periodontol. 2008;35:292-304.
9. Quirynen M, De Soete M, van Steenberghe D. Infectious risks for oral implants: a review of the literature. Clin Oral Implants Res. 2002;13: 1-19.
10. Pye AD, Lockhart DE, Dawson MP, Murray CA, Smith AJ. A review of dental implants and infection. J Hosp Infect. 2009;72:104-110.
11. Quirynen M, Teughels W. Microbiologically compromised patients and impact on oral implants. Periodontol 2000. 2003;33:119-128.
12. Mombelli A, van Oosten MA, Schurch EJ, Land NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol. 1987;2:145-151.
13. Leonhardt A, Renvert S, Dahlen G. Microbial findings at failing implants. Clin Oral Implants Res. 1999;10:339-345.
14. Paster BJ, Boches SK, Galvin JL, etal. Bacterial diversity in human subgingival plaque. J Bacteriol. 2001;183:3770-3783.
15. Zhao L, Chu PK, Zhang Y, Wu Z. Antibacterial coatings on titanium implants. J Biomed Mater Res B Appl Biomater. 2009;91:470-480.
16. Feres M, Haffajee AD, Allard K, Som S, Goodson JM, Socransky SS. Antibiotic resistance of subgingival species during and after antibiotic therapy. J Clin Periodontol. 2002;29:724-735.
17. Prieto-Prieto J, Calvo A. Microbiological basis of oral infections and sensitivity to antibiotics. Med Oral Patol Oral Cir Bucal. 2004;9 Suppl: 11-18.
18. de Nys R, Givskov M, Kumar N, Kjelleberg S, Steinberg PD. Furanones. Prog Mol Subcell Biol. 2006;42:55-86.
19. Ren D, Bedzyk LA, Ye RW, Thomas SM, Wood TK. Differential gene expression shows natural brominated furanones interfere with the autoinducer-2 bacterial signaling system of Escherichia coli. Biotechnol Bioeng. 2004;88:630-642.
20. Janssens JC, Steenackers H, Robijns S, etal. Brominated furanones inhibit biofilm formation by Salmonella enterica serovar Typhimurium. Appl Environ Microbiol. 2008;74:6639-6648.
21. Kuehl R, Al-Bataineh S, Gordon O, etal. Furanone at subinhibitory concentrations enhances staphylococcal biofilm formation by luxS repression. Antimicrob Agents Chemother. 2009;53:4159-4166.
22. Ren D, Bedzyk LA, Ye RW, Thomas SM, Wood TK. Differential gene expression shows natural brominated furanones interfere with the autoinducer-2 bacterial signaling system of Escherichia coli. Biotechnol Bioeng. 2004;88:630-642.
23. Daniels R, Vanderleyden J, Michiels J. Quorum sensing and swarming migration in bacteria. FEMS Microbiol Rev. 2004;28:261-289.
24. Raffa RB, Iannuzzo JR, Levine DR, etal. Bacterial communication ("quorum sensing") via ligands and receptors: a novel pharmacologic target for the design of antibiotic drugs. J Pharmacol Exp Ther. 2005;312:417-423.
25. Baveja JK, Li G, Nordon RE, etal. Biological performance of a novel synthetic furanone-based antimicrobial. Biomaterials. 2004;25: 5013-5021.
26. Hume EB, Baveja J, Muir B, etal. The control of Staphylococcus epidermidis biofilm formation and in vivo infection rates by covalently bound furanones. Biomaterials. 2004;25:5023-5030.
27. Baveja JK, Willcox MD, Hume EB, Kumar N, Odell R, Poole-Warren LA. Furanones as potential anti-bacterial coatings on biomaterials. Biomaterials. 2004;25:5003-5012.
28. Lonn-Stensrud J, Landin MA, Benneche T, Petersen FC, Scheie AA. Furanones, potential agents for preventing Staphylococcus epidermidis biofilm infections? J Antimicrob Chemother. 2009;63:309-316.
29. Pancholi K. A review of imaging methods for measuring drug release at nanometre scale: a case for drug delivery systems. Expert Opin Drug Deliv. 2012;9:203-218.
30. Kashi TS, Eskandarion S, Esfandyari-Manesh M, etal. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int J Nanomedicine. 2012;7:221-234.
31. Le Guehennec L, Soueidan A, Layrolle P, Amouriq Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent Mater. 2007;23:844-854.
32. Guida L, Annunziata M, Rocci A, Contaldo M, Rullo R, Oliva A. Biological response of human bone marrow mesenchymal stem cells to fluoride-modified titanium surfaces. Clin Oral Implants Res. 2010;21: 1234-1241.
33. Mendonca G, Mendonca DB, Aragao FJ, Cooper LF. Advancing dental implant surface technology-from micron-to nanotopography. Biomaterials. 2008;29:3822-3835.
34. Annunziata M, Oliva A, Buosciolo A, Giordano M, Guida A, Guida L. Bone marrow mesenchymal stem cell response to nano-structured oxidized and turned titanium surfaces. Clin Oral Implants Res. 2012;23: 733-740.
35. 3system solution: microstructure, mechanical and tribological properties. Surf Coat Technol. 2006;201: 82-89.
36. Yao ZP, Jiang ZH, Wu XH, Sun XT, Wu ZD. Effects of ceramic coating by micro-plasma oxidation on the corrosion resistance of Ti-6Al-4V alloy. Surf Coat Technol. 2005;200:2445-2450.
37. Wu J, Liu ZM, Zhao XH, Gao Y, Hu J, Gao B. Improved biological performance of microarc-oxidized low-modulus Ti-24Nb-4Zr-7.9Sn alloy. J Biomed Mater Res B Appl Biomater. 2010;92:298-306.
38. Wei D, Zhou Y, Jia D, Wang Y. Characteristic and in vitro bioactivity of a microarc-oxidized TiO(2)-based coating after chemical treatment. Acta Biomater. 2007;3:817-827.
39. Xu XH, Lu P, Guo MQ, Fang MZ. Cross-linked gelatin/nanoparticles composite coating on micro-arc oxidation film for corrosion and drug release. Appl Surf Sci. 2010;256:2367-2371.
40. Yoshizawa H, Nishino S, Shiomori K, Natsugoe S, Aiko T, Kitamura Y. Surface morphology control of polylactide microspheres enclosing irinotecan hydrochloride. Int J Pharm. 2005;296:112-116.
41. Lee JW, Gardella JJ, Hicks WJ, Hard R, Bright FV. Analysis of the initial burst of drug release coupled with polymer surface degradation. Pharm Res. 2003;20:149-152.
42. Fu K, Pack DW, Klibanov AM, Langer R. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res. 2000;17:100-106.
43. Lim YW, Kwon SY, Sun DH, Kim HE, Kim YS. Enhanced cell integration to titanium alloy by surface treatment with microarc oxidation: a pilot study. Clin Orthop Relat Res. 2009;467:2251-2258.
44. Annunziata M, Oliva A, Basile MA, etal. The effects of titanium nitride-coating on the topographic and biological features of TPS implant surfaces. J Dent. 2011;39:720-728.
45. Stigter M, Bezemer J, de Groot K, Layrolle P. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release. 2004;99: 127-137.
46. Ince A, Schutze N, Hendrich C, Jakob F, Eulert J, Lohr JF. Effect of polyhexanide and gentamycin on human osteoblasts and endothelial cells. Swiss Med Wkly. 2007;137:139-145.
47. Kozlovsky A, Artzi Z, Moses O, Kamin-Belsky N, Greenstein RB. Interaction of chlorhexidine with smooth and rough types of titanium surfaces. J Periodontol. 2006;77:1194-1200.
48. Quirynen M, Vogels R, Peeters W, van Steenberghe D, Naert I, Haffajee A. Dynamics of initial subgingival colonization of 'pristine' peri-implant pockets. Clin Oral Implants Res. 2006;17:25-37.
49. Quirynen M, Vogels R, Alsaadi G, Naert I, Jacobs R, van Steenberghe D. Predisposing conditions for retrograde peri-implantitis, and treatment suggestions. Clin Oral Implants Res. 2005;16:599-608.